ICICI Securities has maintained a Buy rating on the company with a target price of INR 1,786, while Axis Capital and Nuvama have set their target prices at INR 1,780 and INR 1,376, respectively, indicating a potential upside of up to 75% in the stock price.

Signature Global’s stock opened at Rs. 1029.90 per share on November 11, 2025, in early trading hours.

During H1FY26, the company recorded strong pre-sales of INR 46.6 billion and reported revenue of INR 12.0 billion, with collections standing at INR 18.7 billion. The company expects collections to rise significantly in H2FY26 as key construction milestones are achieved in its high-value projects located in Gurugram.

Brokerage Firm Recommendations

ICICI Securities has maintained its BUY rating and has updated the target price to Rs 1,786, suggesting the stock could increase by 75%.

The brokerage firm noted that Signature Global has delivered 57% sales booking CAGR over FY21–25, largely through affordable/ mid-income housing projects.

ICICI Securities projects that, backed by Signature Global’s robust launch pipeline with a cumulative gross development value (GDV) exceeding INR 450 billion for FY25–28E, the company’s sales bookings are expected to reach INR 119 billion in FY26, INR 127 billion in FY27, and INR 139 billion in FY28.

Axis Securities expects a 74% upside in the company’s stock price and believes that Signature Global is well-positioned to achieve this target, driven by a strong launch pipeline of over INR 130 billion planned for the second half of the fiscal year.

“We expect construction of new projects to pick up sequentially from here on, which, with healthy bookings at new launches, will drive collections and OCF,” Axis Capital said in its report.

Nuvama has also maintained its BUY rating with a target price of Rs. 1,376 per share.

“Despite being a relatively new entrant, Signature Global has emerged as one of the largest developers in the Gurugram housing market in terms of sales bookings over the past few years,” Nuvama said in its report.

“One of the biggest factors in SGIL’s success is the fact that the company has been able to acquire land at very attractive prices. On average, land/approval-related costs for the company are 10–15% of the selling price,” the report added.

The post ICICI Securities, Axis Capital, and Nuvama Project Up to 75% Growth Potential for Signature Global Stock appeared first on NRI News.

NEW DELHI: FIITJEE, India’s leading coaching institute for JEE and other competitive examinations, is delighted to announce the ‘Masters of Diagnosis’ – Diagnostic cum Scholarship Tests for Students of Class VI, VII, VIII, IX, X, XI & XII. This is a rare and distinctive opportunity for students to assess their academic capabilities and secure admission in the extraordinary world of FIITJEE.

The diagnostic cum Scholarship test is comprehensively designed to assess the current knowledge and potential of students. Through this test, students will be able to diagnose their current and hidden academic potential. They will be given a proper analysis of their IQ, Analytical and Logical Skills, and Problem-Solving Capabilities, which are pivotal for clearing various competitive and scholastic exams and dealing even with various problems life throws at us.

Since its inception, FIITJEE has established an unprecedented legacy in the domain of JEE Main & JEE Advanced and other competitive & scholastic exams. Over the years, FIITJEE has produced JEE toppers, demonstrating the significance of its teaching methodologies and commitment to academic excellence. The institute’s outstanding expertise, proficient faculty, and comprehensive pattern-proof study materials have contributed to its reputation as a premier coaching institute.

While FIITJEE’s prominence primarily revolves around JEE preparation, it is important to note that under the ‘Masters of Diagnosis’, the Diagnostic cum Scholarship test is not solely aimed at JEE aspirants. This test is prepared to assess students’ foundational knowledge and academic abilities across diverse disciplines.

The Diagnostic Cum Scholarship Tests give students access to the FIITJEE’s universe and serve as a diagnostic tool for assessing their academic potential. The renowned pedagogy of FIITJEE will prime them for remarkable performance in JEE Main and Advanced, NTSE, INSPIRE (previous KVPY), and various Olympiads.

And, if a student opts for a non-engineering stream/career, then FIITJEE’s education module will develop the various skills in students like time management strategies, logical thinking, and analytical ability, which are extremely crucial for various competitive and scholastic exams as well as for dealing with various real-life problems.

”The Masters of Diagnosis echoes FIITJEE’s commitment to fostering holistic academic development in any stream of education. By providing a comprehensive assessment that transcends JEE preparation, the institute aims to empower students with the essential skills and knowledge required for success in various academic pursuits. It reflects FIITJEE’s sincere intent of developing and nurturing well-rounded personalities fully equipped to thrive in these highly competitive and challenging times,” said R L Trikha, Director, FIITJEE Group.

The tests will be conducted on April 28^th, 2024, and are open to students from Class VI, VII, VIII, IX, X, XI & XII. The tests will be conducted in the pattern of JEE and other competitive and scholastic exams, with Objective-type questions from IQ, Science, and Mathematics (for Class VI to X) and IQ, Physics, Chemistry and Mathematics (for Class XI, XII & XII Appeared). The exam syllabi for all classes (VI to XII) will constitute the full syllabus of the previous Class.

Individuals must complete their registration before 26th April 2024.

The post FIITJEE Introduces Diagnostic Cum Scholarship Tests For Students To Assess Aptitude & Success Potential appeared first on NRI News.